Advisory Board
Charles Boucher
|
Charles Boucher MD, PhD
c.boucher@lab.azu.nl
Utrecht University, Utrecht, The Netherlands
Position
Associate Professor, Department of Medical Microbiology, Utrecht University
Date of Birth
January 16, 1958
Education
University of Amsterdam (MD Degree cum laude)
Academic Medical Centre, University of Amsterdam
(Medical microbiologist training)
University of Amsterdam, Faculty of Medicine (PhD)
Recent Publications
Lamivudine-resistant human immunodeficiency
virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo.
Nijhuis M; Boucher CA; de Groot T; Keulen W, Danner S; Lange J; van Leeuwen R; de Jong D; Schuurman R. Journal of Infectious Diseases 1997; 176:398-405.
The duration of viral suppression is predicted by viral load during protease inhibitor therapy. Kempf D; Leonard J; Boucher C; Danner S; Sun E Molla A. 4th Conf Retro and Opportun Infect. 1997 Jan 22-26;:176 (abstract no. 603).
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.
Molla A; Kempf DJ; Norbeck DW; Leonard JM; Boucher CA; et al. Nat Med. 1996 Jul;2(7):760-6.
|
